Company / Tangible Book Value per Share
Fulgent Genetics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$35.24
FY2025
5-year range
$35.24 / $39.32
FY2021-FY2025
Trend
-6.0%
vs FY2024
Sector context
#15 of 158
Health Care
What the data says
Among 158 Health Care companies, Fulgent Genetics, Inc. is in the top 9% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $0.29 in FY2016 to $39.32 in FY2021.
Based on SEC 10-K filings.
35.24 in FY2025 with a 5-year CAGR of +5.9%. Top quartile in the Health Care sector.
Declined from $37.84 to $35.24 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -1.8%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
+90.8% above sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 6.0% year-over-year.
- Ranks #15 out of 158 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.24 | -6.0% |
| FY2024 | $37.47 | -1.0% |
| FY2023 | $37.84 | +1.6% |
| FY2022 | $37.26 | -5.2% |
| FY2021 | $39.32 | +48.3% |
| FY2020 | $26.50 | +841.6% |
| FY2019 | $2.81 | -7.3% |
| FY2018 | $3.04 | -1.0% |
| FY2017 | $3.07 | +952.8% |
| FY2016 | $0.29 | -33.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026